CY1125395T1 - Αντιμικροβιακες συνθεσεις με αναβραζουσες ουσιες - Google Patents
Αντιμικροβιακες συνθεσεις με αναβραζουσες ουσιεςInfo
- Publication number
- CY1125395T1 CY1125395T1 CY20211100955T CY211100955T CY1125395T1 CY 1125395 T1 CY1125395 T1 CY 1125395T1 CY 20211100955 T CY20211100955 T CY 20211100955T CY 211100955 T CY211100955 T CY 211100955T CY 1125395 T1 CY1125395 T1 CY 1125395T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compositions
- antimicrobial compositions
- effecting
- substances
- effecting substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Η παρούσα εφεύρεση αφορά σε φαρμακευτικές συνθέσεις, οι οποίες περιλαμβάνουν έναν αντιμικροβιακό παράγοντα παραγώγου του καρβοξυλικού οξέος της κινολόνης και μία αναβράζουσα ουσία. Οι εν λόγω συνθέσεις έχουν βελτιωμένη ανεκτικότητα από το γαστρεντερικό ή/και μειωμένη πιθανότητα να προκαλέσουν παρενέργειες στο γαστρεντερικό. Αυτές οι συνθέσεις είναι χρήσιμες για από του στόματος χορήγηση για τη θεραπευτική αντιμετώπιση, την πρόληψη ή τη μείωση του κινδύνου μικροβιακών λοιμώξεων.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462014786P | 2014-06-20 | 2014-06-20 | |
EP15810507.2A EP3157510B1 (en) | 2014-06-20 | 2015-06-19 | Antimicrobial compositions with effervescent agents |
PCT/US2015/036605 WO2015196027A1 (en) | 2014-06-20 | 2015-06-19 | Antimicrobial compositions with effervescent agents |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1125395T1 true CY1125395T1 (el) | 2023-03-24 |
Family
ID=54868661
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20191100664T CY1121995T1 (el) | 2014-06-20 | 2019-06-26 | Αντιμικροβιακες συνθεσεις με αναβραζουσες ουσιες |
CY20211100955T CY1125395T1 (el) | 2014-06-20 | 2021-11-04 | Αντιμικροβιακες συνθεσεις με αναβραζουσες ουσιες |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20191100664T CY1121995T1 (el) | 2014-06-20 | 2019-06-26 | Αντιμικροβιακες συνθεσεις με αναβραζουσες ουσιες |
Country Status (31)
Country | Link |
---|---|
US (2) | US20150366857A1 (el) |
EP (3) | EP3157510B1 (el) |
JP (2) | JP6995479B2 (el) |
CN (2) | CN106572982B9 (el) |
AR (1) | AR100920A1 (el) |
AU (3) | AU2015276954B2 (el) |
BR (1) | BR112016029761B1 (el) |
CA (1) | CA2952950C (el) |
CL (2) | CL2016003273A1 (el) |
CR (2) | CR20200565A (el) |
CY (2) | CY1121995T1 (el) |
DK (2) | DK3157510T3 (el) |
EA (1) | EA034152B1 (el) |
EC (1) | ECSP16095540A (el) |
ES (2) | ES2732865T3 (el) |
HR (2) | HRP20211685T1 (el) |
HU (2) | HUE044764T2 (el) |
IL (1) | IL249622A0 (el) |
LT (2) | LT3157510T (el) |
MX (2) | MX368940B (el) |
PE (2) | PE20210927A1 (el) |
PH (1) | PH12016502548A1 (el) |
PL (2) | PL3157510T3 (el) |
PT (2) | PT3581180T (el) |
RS (2) | RS62538B1 (el) |
SI (2) | SI3581180T1 (el) |
SV (1) | SV2016005349A (el) |
TR (1) | TR201909417T4 (el) |
TW (2) | TWI732337B (el) |
UY (1) | UY36184A (el) |
WO (1) | WO2015196027A1 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022240897A1 (en) * | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194617A (en) * | 1988-12-17 | 1993-03-16 | Meiji Seika Kaisha, Ltd. | 2,3-disubstituted-4-hydroxyquinoline derivatives |
US5223264A (en) * | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
PT911327E (pt) | 1995-09-22 | 2002-05-31 | Wakunaga Pharma Co Ltd | Novos derivados do acido piridonocarboxilico ou seus sais e agente antibacteriano compreendendo os mesmos como o ingrediente activo |
US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
NZ510487A (en) | 1998-09-14 | 2003-04-29 | Ranbaxy Lab Ltd | Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form |
US6187317B1 (en) * | 1999-07-14 | 2001-02-13 | Judith Taylor | Natural anti-diarrheal composition and method |
US6414036B1 (en) * | 1999-09-01 | 2002-07-02 | Van Beek Global/Ninkov Llc | Composition for treatment of infections of humans and animals |
JP2005097116A (ja) | 1999-11-11 | 2005-04-14 | Wakunaga Pharmaceut Co Ltd | キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法 |
US7157100B2 (en) * | 2002-06-04 | 2007-01-02 | J.B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical composition for controlled drug delivery system |
EP2305666B1 (en) | 2004-07-30 | 2014-06-25 | AbbVie Inc. | Preparation of pyridonecarboxylic acid antibacterials |
HUE056718T2 (hu) * | 2004-10-08 | 2022-03-28 | Abbvie Inc | Hatóanyag (delafloxacin) meglumin sója és ennek kristályos formái |
PL2486942T3 (pl) * | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
MX2007012642A (es) | 2005-04-11 | 2008-01-11 | Abbott Lab | Composiciones farmaceuticas que tienen perfiles mejorados de disolucion para farmacos poco solubles. |
EP1745775B1 (en) | 2005-07-19 | 2008-05-28 | Ethypharm | Gastroretentive formulations and manufacturing process thereof. |
US7611739B2 (en) | 2006-01-06 | 2009-11-03 | Amerilab Technologies, Inc. | Method of using guava extract and composition including guava extract |
WO2008021256A2 (en) * | 2006-08-11 | 2008-02-21 | Aqua Resources Corporation | Nanoplatelet metal hydroxides and methods of preparing same |
CN1943561A (zh) * | 2006-08-23 | 2007-04-11 | 北京阜康仁生物制药科技有限公司 | 普卢利沙星口腔崩解片及其制备方法 |
PL2124884T3 (pl) | 2006-12-22 | 2020-01-31 | Ironwood Pharmaceuticals, Inc. | Metody i kompozycje do leczenia zaburzeń przełyku |
WO2008148798A2 (en) * | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
JP6063123B2 (ja) * | 2008-11-15 | 2017-01-18 | メリンタ セラピューティクス、インク | 抗菌性組成物 |
WO2010096551A2 (en) * | 2009-02-18 | 2010-08-26 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compositions |
GB201020076D0 (en) * | 2010-11-26 | 2011-01-12 | Liverpool School Tropical Medicine | Antimalarial compounds |
KR101875720B1 (ko) * | 2011-01-10 | 2018-07-09 | 인피니티 파마슈티칼스, 인코포레이티드 | 이소퀴놀린온 및 이의 고체 형태의 제조 방법 |
WO2012097273A1 (en) * | 2011-01-14 | 2012-07-19 | Vertex Pharmaceuticals Incorporated | Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea |
JP2013034468A (ja) * | 2011-08-10 | 2013-02-21 | Nisshin Sugar Mfg Co Ltd | 発泡成型甘味料 |
WO2013090893A1 (en) * | 2011-12-16 | 2013-06-20 | Celanese Eva Performance Polymers, Inc. | Gastroretentive controlled release vehicles that include ethylene copolymers, ethyl celluloses, and/or thermpoplastic polyurethanes |
CN102697751A (zh) * | 2012-05-30 | 2012-10-03 | 河南牧翔动物药业有限公司 | 一种畜禽专用恩诺沙星泡腾分散片及其制备方法 |
-
2015
- 2015-06-18 TW TW108140999A patent/TWI732337B/zh active
- 2015-06-18 TW TW104119676A patent/TWI705814B/zh active
- 2015-06-19 MX MX2016017350A patent/MX368940B/es active IP Right Grant
- 2015-06-19 AU AU2015276954A patent/AU2015276954B2/en active Active
- 2015-06-19 ES ES15810507T patent/ES2732865T3/es active Active
- 2015-06-19 ES ES19165084T patent/ES2897576T3/es active Active
- 2015-06-19 PE PE2021000031A patent/PE20210927A1/es unknown
- 2015-06-19 CR CR20200565A patent/CR20200565A/es unknown
- 2015-06-19 TR TR2019/09417T patent/TR201909417T4/tr unknown
- 2015-06-19 LT LTEP15810507.2T patent/LT3157510T/lt unknown
- 2015-06-19 RS RS20211307A patent/RS62538B1/sr unknown
- 2015-06-19 BR BR112016029761-0A patent/BR112016029761B1/pt active IP Right Grant
- 2015-06-19 JP JP2016574040A patent/JP6995479B2/ja active Active
- 2015-06-19 PL PL15810507T patent/PL3157510T3/pl unknown
- 2015-06-19 EP EP15810507.2A patent/EP3157510B1/en active Active
- 2015-06-19 CN CN201580044451.8A patent/CN106572982B9/zh active Active
- 2015-06-19 SI SI201531733T patent/SI3581180T1/sl unknown
- 2015-06-19 CA CA2952950A patent/CA2952950C/en active Active
- 2015-06-19 PT PT191650845T patent/PT3581180T/pt unknown
- 2015-06-19 HU HUE15810507 patent/HUE044764T2/hu unknown
- 2015-06-19 SI SI201530783T patent/SI3157510T1/sl unknown
- 2015-06-19 CN CN202210565182.1A patent/CN114831955B/zh active Active
- 2015-06-19 EA EA201692532A patent/EA034152B1/ru unknown
- 2015-06-19 EP EP19165084.5A patent/EP3581180B1/en active Active
- 2015-06-19 WO PCT/US2015/036605 patent/WO2015196027A1/en active Application Filing
- 2015-06-19 US US14/744,432 patent/US20150366857A1/en not_active Abandoned
- 2015-06-19 PE PE2016002748A patent/PE20170304A1/es unknown
- 2015-06-19 RS RS20190773A patent/RS59064B1/sr unknown
- 2015-06-19 HR HRP20211685TT patent/HRP20211685T1/hr unknown
- 2015-06-19 PL PL19165084T patent/PL3581180T3/pl unknown
- 2015-06-19 PT PT15810507T patent/PT3157510T/pt unknown
- 2015-06-19 HU HUE19165084A patent/HUE056298T2/hu unknown
- 2015-06-19 AR ARP150101976A patent/AR100920A1/es unknown
- 2015-06-19 DK DK15810507.2T patent/DK3157510T3/da active
- 2015-06-19 EP EP21188004.2A patent/EP3919057A1/en active Pending
- 2015-06-19 DK DK19165084.5T patent/DK3581180T3/da active
- 2015-06-19 LT LTEP19165084.5T patent/LT3581180T/lt unknown
- 2015-06-19 CR CR20160592A patent/CR20160592A/es unknown
- 2015-06-22 UY UY0001036184A patent/UY36184A/es not_active Application Discontinuation
-
2016
- 2016-12-18 IL IL249622A patent/IL249622A0/en unknown
- 2016-12-20 SV SV2016005349A patent/SV2016005349A/es unknown
- 2016-12-20 CL CL2016003273A patent/CL2016003273A1/es unknown
- 2016-12-20 EC ECIEPI201695540A patent/ECSP16095540A/es unknown
- 2016-12-20 PH PH12016502548A patent/PH12016502548A1/en unknown
- 2016-12-20 MX MX2019012608A patent/MX2019012608A/es unknown
-
2019
- 2019-06-21 HR HRP20191133TT patent/HRP20191133T1/hr unknown
- 2019-06-26 CY CY20191100664T patent/CY1121995T1/el unknown
-
2020
- 2020-01-28 US US16/774,709 patent/US20200237744A1/en not_active Abandoned
- 2020-07-15 JP JP2020121083A patent/JP7149991B2/ja active Active
- 2020-10-17 AU AU2020256457A patent/AU2020256457B2/en active Active
- 2020-12-03 CL CL2020003153A patent/CL2020003153A1/es unknown
-
2021
- 2021-11-04 CY CY20211100955T patent/CY1125395T1/el unknown
- 2021-12-14 AU AU2021286284A patent/AU2021286284B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124959T1 (el) | Αναστολεις λυσινης ειδικης απομεθυλασης-1 | |
CY1123381T1 (el) | Συνθεσεις που περιεχουν βακτηριακα στελεχη | |
CY1123595T1 (el) | Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 | |
CY1122142T1 (el) | Συνθεσεις που περιλαμβανουν στελεχη του βακτηριου blautia για τη θεραπευτικη αγωγη σπλαγχνικης υπερευαισθησιας | |
CY1124548T1 (el) | Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου του δαγκειου ιου | |
DK3565550T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan | |
CY1123033T1 (el) | Σπειροκυκλικοι αναστολεις της καθεψινης c | |
CY1123963T1 (el) | Καινοτομα πολυμερικα προφαρμακα hgh | |
EA201691421A1 (ru) | Гетероарилы и их применение | |
CY1123189T1 (el) | Αντιμικροβiακο πεπτιδιο | |
CY1120490T1 (el) | Φαρμακο για την προληψη και/ή την θεραπευτικη αντιμετωπιση της πολυκυστικης νοσου των νεφρων | |
CY1121554T1 (el) | Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης | |
EA201692091A1 (ru) | Хиноксалиновые соединения и их применение | |
EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
MA46867A (fr) | Formulations pharmaceutiques | |
CY1123844T1 (el) | Φαρμακευτικες συνθεσεις και χρησεις που απευθυνονται σε διαταραχες λυσοσωμιακης αποθηκευσης | |
DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
CY1122473T1 (el) | Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης | |
CY1121171T1 (el) | Πυρογλουταμικη βορτιοξετινη | |
CY1124967T1 (el) | Παραγωγα αμινοπυριδινης και χρηση αυτων ως εκλεκτικοι αναστολεις alk-2 | |
CY1124286T1 (el) | Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη | |
BR112018074985A2 (pt) | composições antibacterianas | |
MA55015A (fr) | Formulations pharmaceutiques | |
DK3870234T3 (da) | Antistoflægemiddelkonjugater omfattende ecteinascidinderivater | |
CY1125395T1 (el) | Αντιμικροβιακες συνθεσεις με αναβραζουσες ουσιες |